ERIKA DE REYNOSA, S.A. DE C.V. FMC BLOODLINE; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
|
Back to Search Results |
|
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problem
Cardiac Arrest (1762)
|
Event Date 01/22/2018 |
Event Type
Injury
|
Manufacturer Narrative
|
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
|
|
Event Description
|
An area technical operations manager (atom) at a user facility reported that a patient had a cardiac arrest during hemodialysis (hd) treatment while on a fresenius 2008t hd machine.There were no diagnostic messages or audible alarms.The atom stated that the patient was taken to the hospital and did not complete hd treatment.No further information regarding the patient status has been made available.There were no reported problems during the patient treatment prior to the event.Following the event, the machine was removed from service for evaluation by the user facility¿s atom.The atom ran simulated use testing and all functional and ultrafiltration testing on the machine and no problems were identified.The atom verified machine operations.No repairs were required.The machine remains out of service pending culture results.No defect or malfunction of any fresenius product in use during the hd treatment was observed or identified.No devices were stated to be available to be returned to the manufacturing plant for physical evaluation.
|
|
Manufacturer Narrative
|
There is no documentation to show a causal relationship between the patient event of cardiac arrest and the 2008t hemodialysis (hd) machine.Additionally, there is no allegation of a machine malfunction.However, there is a temporal relationship between hd therapy on the 2008t machine and the cardiac arrest as the patient was completing treatment at the time of the event.Per the biomedical technician, the machine passed all testing after the event.It is unknown if the patient had comorbidities or was taking any medication that could have caused or contributed to the cardiac arrest.Based on available information, the cause of the cardiac arrest is unknown.
|
|
Manufacturer Narrative
|
Follow-up #2 device evaluation: a sample was not returned to the manufacturer for physical evaluation and the lot number or catalog number was not provided.Therefore, the complaint cannot be confirmed.A manufacturing review was performed on the lot numbers for all bloodline products shipped to the facility for the three (3) month time frame which immediately preceded the event occurrence date.A records review was performed on the 11 lots identified by the manufacturer.The device history record (dhr) was reviewed on these lots and confirmed that there were no non-conformances or any other occurrence in production identified during the manufacturing process which could be associated with the reported event.All the applicable in-process and final quality control tests were found to be without acceptable results for the 11 lots identified in this review.All lots met the required release criteria.A definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint sample.
|
|
Search Alerts/Recalls
|
|
|